Skip to content

NMIN

PRESS RELEASES

NMIN Board of Directors names Dr. Gilbert Walker Scientific Director & CEO

The Board of Directors of the NanoMedicines Innovation Network (NMIN), a national Networks of Centres of Excellence (NCE) funded by the Government of Canada, has appointed Dr. Gilbert Walker Scientific Director & CEO, effective 14 September 2022.

VANCOUVER, BC (23 September 2022)

NMIN’s Founding Scientific Director wins 2022 Canada Gairdner International Award

The Gairdner Foundation announced the 2022 award laureates in a press release on 5 April 2022, noting that the work of Drs Pieter Cullis, Katalin Kariko and Drew Weissman “enabled the rapid availability of highly effective and safe COVID-19 mRNA vaccines, which has become an important tool for the control of COVID-19 pandemic.”

VANCOUVER, BC (5 April 2022)

NMIN’s Founding Scientific Director wins VinFuture Foundation’s first global sci-tech award

Dr. Cullis and colleagues at the University of British Columbia (UBC) and Acuitas Therapeutics, a company he co-founded, developed the indispensable “made in Canada” lipid nanoparticle technology used by these vaccines to deliver mRNA into target cells.

VANCOUVER, BC (24 January 2022)

Canadian scientist awarded international prize for COVID vaccine technology

Canadian scientist Dr. Pieter Cullis, together with his peers Drs Katalin Kariko and Drew Weissman, have been honoured with the 2021 Prince Mahidol Award for their contributions to the development of COVID-19 messenger RNA (mRNA) vaccines.
VANCOUVER, BC (17 November 2021)

NMIN names new Scientific Director & CEO Dr. Christine Allen

The NanoMedicines Innovation Network (NMIN), a national research network funded by the Government of Canada, has appointed Dr. Christine Allen Scientific Director & CEO, effective 1 July 2021.
VANCOUVER, BC (18 June 2021)

 

Canadian technology enables Pfizer’s promising COVID-19 vaccine

Pfizer has caught the world’s attention with its promising early results for a COVID-19 vaccine candidate. What has been less widely publicized is the pivotal role of Canadian know-how and technology in the development of this potential vaccine.

VANCOUVER, BC (12 November 2020)

 

Gene therapy enabled by nanotechnology: A new era of medicine

NanoMedicines Innovation Network (NMIN) thought leaders contribute to a commentary in the December 2019 issue of Nature Nanotechnology

VANCOUVER, BC (4 December 2019)